Literature DB >> 13673139

Persistence of type-specific antibodies in man following infection with group A streptococci.

R C LANCEFIELD.   

Abstract

Whole blood or sera were collected from individuals who had had infections with Group A streptococci of known serological type as long ago as 10 to 32 years. Most of these patients had not been treated with chemotherapeutic drugs. By means of bactericidal tests with all these sera, and mouse protection tests with some, type-specific antibodies could be demonstrated in at least half of them after a lapse of many years, the longest interval being 32 years. Two biological methods for estimating the amount of M antigen produced by Group A streptococci are described. By selecting strains for use by these methods, optimal proportions of M antigen and antibody could be employed in the tests and small amounts of antibody were, therefore, demonstrable. The assay methods for M antigen are also of value for other experimental purposes.

Entities:  

Keywords:  STREPTOCOCCAL INFECTIONS/immunology

Mesh:

Substances:

Year:  1959        PMID: 13673139      PMCID: PMC2136986          DOI: 10.1084/jem.110.2.271

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  Type-specific streptococcal antibody.

Authors:  F W DENNY; W D PERRY; L W WANNAMAKER
Journal:  J Clin Invest       Date:  1957-07       Impact factor: 14.808

2.  Studies on immunity to streptococcal infections in man.

Authors:  L W WANNAMAKER; F W DENNY; W D PERRY; A C SIEGEL; C H RAMMELKAMP
Journal:  AMA Am J Dis Child       Date:  1953-09

3.  THE OCCURRENCE OF BACTERIOSTATIC PROPERTIES IN THE BLOOD OF PATIENTS AFTER RECOVERY FROM STREPTOCOCCAL PHARYNGITIS.

Authors:  A G Kuttner; T F Lenert
Journal:  J Clin Invest       Date:  1944-03       Impact factor: 14.808

4.  Streptococcal bacteriostatic antibody in patients treated with penicillin.

Authors:  G DAIKOS; L WEINSTEIN
Journal:  Proc Soc Exp Biol Med       Date:  1951-10

5.  The relative importance of the capsule and the M-antigen in determining colony form of group A streptococci.

Authors:  A T WILSON
Journal:  J Exp Med       Date:  1959-03-01       Impact factor: 14.307

6.  STUDIES ON THE ANTIGENIC COMPOSITION OF GROUP A HEMOLYTIC STREPTOCOCCI : III. TYPES WITH SEROLOGICALLY IDENTICAL M BUT DISTINCT T ANTIGENS: TYPES 10 AND 12.

Authors:  R F Watson; R C Lancefield
Journal:  J Exp Med       Date:  1944-01-01       Impact factor: 14.307

7.  Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test.

Authors:  R C LANCEFIELD
Journal:  J Exp Med       Date:  1957-10-01       Impact factor: 14.307

8.  BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCI : I. TYPE-SPECIFIC ANTIBODIES IN SERA OF PATIENTS CONVALESCING FROM GROUP A STREPTOCOCCAL PHARYNGITIS.

Authors:  S Rothbard
Journal:  J Exp Med       Date:  1945-08-01       Impact factor: 14.307

9.  TYPE-SPECIFIC PROTECTION AND IMMUNITY FOLLOWING INTRANASAL INOCULATION OF MONKEYS WITH GROUP A HEMOLYTIC STREPTOCOCCI.

Authors:  R F Watson; S Rothbard; H F Swift
Journal:  J Exp Med       Date:  1946-07-31       Impact factor: 14.307

10.  Occurrence of R antigen specific for Group A type 3 streptococci.

Authors:  R C LANCEFIELD
Journal:  J Exp Med       Date:  1958-09-01       Impact factor: 14.307

View more
  98 in total

1.  Immunogenicity of a 26-valent group A streptococcal vaccine.

Authors:  Mary C Hu; Michael A Walls; Steven D Stroop; Mark A Reddish; Bernard Beall; James B Dale
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  The amino-terminal region of group A streptococcal M protein determines its molecular state of assembly and function.

Authors:  K M Khandke; T Fairwell; E H Braswell; B N Manjula
Journal:  J Protein Chem       Date:  1991-02

3.  Identification of a divergent M protein gene and an M protein-related gene family in Streptococcus pyogenes serotype 49.

Authors:  E J Haanes; P P Cleary
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

4.  STUDIES ON TYPE-SPECIFIC STREPTOCOCCAL ANTIBODIES AS INDICATORS OF PREVIOUS STREPTOCOCCAL INFECTIONS IN RHEUMATIC AND NONRHEUMATIC CHILDREN.

Authors:  M Markowitz
Journal:  J Clin Invest       Date:  1963-03       Impact factor: 14.808

5.  Recall of type specific antibodies in man by injections of streptococcal cell walls.

Authors:  E V POTTER; G H STOLLERMAN; A C SIEGEL
Journal:  J Clin Invest       Date:  1962-02       Impact factor: 14.808

6.  The prospect of vaccination against group A beta-hemolytic streptococci.

Authors:  Karen L Kotloff
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

7.  Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies.

Authors:  G B Pier; G Meluleni; J B Goldberg
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

8.  Age-associated differences in prevalence of group A streptococcal type-specific M antibodies in children.

Authors:  Preeti Jaggi; James B Dale; Edna Chiang; Poonam Beniwal; William Kabat; Stanford T Shulman
Journal:  Eur J Pediatr       Date:  2008-09-24       Impact factor: 3.183

9.  A Single Amino Acid Replacement in the Sensor Kinase LiaS Contributes to a Carrier Phenotype in Group A Streptococcus.

Authors:  Anthony R Flores; Brittany E Jewell; Dedipya Yelamanchili; Randall J Olsen; James M Musser
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

10.  FATE OF STREPTOCOCCAL M PROTEIN AFTER EXPOSURE TO PLASMIN AND HUMAN LEUKOCYTES.

Authors:  F S KANTOR
Journal:  Yale J Biol Med       Date:  1964-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.